C

Curvebeam AI Ltd
ASX:CVB

Watchlist Manager
Curvebeam AI Ltd
ASX:CVB
Watchlist
Price: 0.125 AUD 8.7% Market Closed
Market Cap: 48.4m AUD
Have any thoughts about
Curvebeam AI Ltd?
Write Note

Curvebeam AI Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Curvebeam AI Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
C
Curvebeam AI Ltd
ASX:CVB
Gross Profit
AU$3m
CAGR 3-Years
56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$11B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Gross Profit
$14B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$23B
CAGR 3-Years
-2%
CAGR 5-Years
5%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$5.3B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
14%
No Stocks Found

Curvebeam AI Ltd
Glance View

Market Cap
48.4m AUD
Industry
Health Care

Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.

CVB Intrinsic Value
0.288 AUD
Undervaluation 57%
Intrinsic Value
Price
C

See Also

What is Curvebeam AI Ltd's Gross Profit?
Gross Profit
3m AUD

Based on the financial report for Jun 30, 2024, Curvebeam AI Ltd's Gross Profit amounts to 3m AUD.

What is Curvebeam AI Ltd's Gross Profit growth rate?
Gross Profit CAGR 3Y
56%

Over the last year, the Gross Profit growth was -32%. The average annual Gross Profit growth rates for Curvebeam AI Ltd have been 56% over the past three years .

Back to Top